Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa.
Trop Med Int Health. 2013 Aug;18(8):934-41. doi: 10.1111/tmi.12135. Epub 2013 Jun 3.
To determine rates of, and factors associated with, disengagement from care in a decentralised antiretroviral programme.
Adults (≥16 years) who initiated antiretroviral therapy (ART) in the Hlabisa HIV Treatment and Care Programme August 2004-March 2011 were included. Disengagement from care was defined as no clinic visit for 180 days, after adjustment for mortality. Cumulative incidence functions for disengagement from care, stratified by year of ART initiation, were obtained; competing-risks regression was used to explore factors associated with disengagement from care.
A total of 4,674 individuals (median age 34 years, 29% male) contributed 13 610 person-years of follow-up. After adjustment for mortality, incidence of disengagement from care was 3.4 per 100 person-years (95% confidence interval (CI) 3.1-3.8). Estimated retention at 5 years was 61%. The risk of disengagement from care increased with each calendar year of ART initiation (P for trend <0.001). There was a strong association between disengagement from care and higher baseline CD4+ cell count (subhazard ratio (SHR) 1.94 (P < 0.001) and 2.35 (P < 0.001) for CD4+ cell count 150-200 cells/μl and >200 cells/μl respectively, compared with CD4 count <50 cells/μl). Of those disengaged from care with known outcomes, the majority (206/303, 68.0%) remained resident within the local community.
Increasing disengagement from care threatens to limit the population impact of expanded antiretroviral coverage. The influence of both individual and programmatic factors suggests that alternative service delivery strategies will be required to achieve high rates of long-term retention.
在一个去中心化的抗逆转录病毒治疗方案中,确定脱离治疗的比率和与脱离治疗相关的因素。
本研究纳入了 2004 年 8 月至 2011 年 3 月在 Hlabisa HIV 治疗和护理方案中开始接受抗逆转录病毒治疗(ART)的成年人(≥16 岁)。脱离治疗被定义为 180 天内无门诊就诊,死亡率校正后。获得按 ART 起始年份分层的脱离治疗累积发生率函数;使用竞争风险回归来探讨与脱离治疗相关的因素。
共有 4674 人(中位年龄 34 岁,29%为男性)提供了 13610 人年的随访。死亡率校正后,脱离治疗的发生率为 3.4/100 人年(95%置信区间 3.1-3.8)。估计 5 年的保留率为 61%。随着 ART 起始年份的增加,脱离治疗的风险增加(趋势 P<0.001)。脱离治疗与较高的基线 CD4+细胞计数密切相关(风险比 1.94(P<0.001)和 2.35(P<0.001),分别与 CD4+细胞计数 150-200 个/μl 和 >200 个/μl 相比,与 CD4 计数 <50 个/μl 相比)。在已知结局的脱离治疗者中,大多数(303 例中的 206 例,68.0%)仍留在当地社区。
脱离治疗的人数不断增加,可能会限制扩大抗逆转录病毒覆盖范围的人群影响。个体和方案因素的影响表明,需要采取替代服务提供策略,才能实现长期保留率的提高。